메뉴 건너뛰기




Volumn 56, Issue 2, 2012, Pages 1133-1134

In vitro activity of JPC 2067 alone and in combination with sulfamethoxazole against Nocardia species

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; DIHYDROFOLATE REDUCTASE INHIBITOR; JPC 2067; SULFAMETHOXAZOLE; UNCLASSIFIED DRUG;

EID: 84856070871     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05855-11     Document Type: Article
Times cited : (11)

References (7)
  • 1
    • 84943128553 scopus 로고
    • Pharmacologic principles
    • WB Saunders, Philadelphia, PA
    • Braude AI. 1976. Pharmacologic principles, p 68. In Antimicrobial Drug Therapy. WB Saunders, Philadelphia, PA.
    • (1976) Antimicrobial Drug Therapy , pp. 68
    • Braude, A.I.1
  • 4
    • 48949118010 scopus 로고    scopus 로고
    • Novel triazine JPC-2067-B Inhibits Toxoplasma gondii in vitro and in vivo
    • doi:10.1371/journal.pntd.0000190
    • Mui EJ, et al. 2008. Novel triazine JPC-2067-B Inhibits Toxoplasma gondii in vitro and in vivo. PLoS Negl. Trop. Dis. 2(3):e190. doi:10.1371/journal. pntd.0000190.
    • (2008) PLoS Negl. Trop. Dis. , vol.2 , Issue.3
    • Mui, E.J.1
  • 5
    • 0020699748 scopus 로고
    • Trimethoprimsulfamethoxazole therapy for Nocardia infections
    • Smego RA, Jr, Moeller MB, Gallis HA. 1983. Trimethoprimsulfamethoxazole therapy for Nocardia infections. Arch. Intern. Med. 143:711-718.
    • (1983) Arch. Intern. Med. , vol.143 , pp. 711-718
    • Smego Jr., R.A.1    Moeller, M.B.2    Gallis, H.A.3
  • 6
    • 0037417078 scopus 로고    scopus 로고
    • Enhanced in vitro activity of dihydrofolate reductase and dihydropteroase synthase inhibitors in combination against Nocardia spp. [2]
    • DOI 10.1128/AAC.47.3.1174.2003
    • Thielking DM, DeStefano MS, Cynamon MH, Yeo AET. 2003. Enhanced in vitro activity of dihydrofolate reductase and dihydropteroase synthase inhibitors in combination against Nocardia spp. Antimicrob. Agents Chemother. 47:1174. (Pubitemid 36254259)
    • (2003) Antimicrobial Agents and Chemotherapy , vol.47 , Issue.3 , pp. 1174
    • Thielking, D.M.1    Destefano, M.S.2    Cynamon, M.H.3    Yeo, A.E.T.4
  • 7
    • 84906831109 scopus 로고    scopus 로고
    • Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes
    • approved standard - second edition. CLSI, Wayne, PA
    • Woods GL, et al. 2011. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard - second edition. CLSI document M24-A2. CLSI, Wayne, PA.
    • (2011) CLSI Document M24-A2
    • Woods, G.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.